August 26, 2022

With Covid pandemic over, Moderna heads to the courts

May 30, 2022

Abbvie to become the biggest of pharmas in 2028

New extended consensus forecasts from Evaluate Pharma show Roche edged out of first place by Abbvie as new blood replaces Humira.

May 25, 2022

The patent winter is coming

Biopharma is approaching the most painful period of patent loss for at least 30 years. Is M&A an answer?

May 23, 2022

Concert alopecia win rubs Salt in its wounds

March 11, 2022

Alvotech settlement completes the list of Humira challengers

May 06, 2021

Biden patent waiver unlikely to hit vaccine sales

September 03, 2020

Amarin forced to look to Europe as US patent hopes dashed

August 20, 2020

Mylan only the first chink in Tecfidera’s armour

August 06, 2020

Eliquis patent win adds a few billion to Bristol and Pfizer